We’ve been working hard on an organizational initiative aimed at deploying extremely successful new technologies, including HPV testing and thermo-coagulation treatment. These will enable Grounds for Health, in collaboration with the global health community, to reach more women for cervical cancer screening and treatment through increased efficiencies and effectiveness. HPV testing will allow us to identify the women at highest risk for cervical cancer. This will result in fewer gynecological exams for women and make recruitment far less difficult. Thermocoagulation provides quicker and less stressful treatment and will be less costly than our current method over the long term.
If successful, our work will demonstrate a more effective path to reaching more women that can be adopted by other organizations worldwide.
From the World Health Organization:
Since 1996, we’ve screened more than 92,037, treated over 6,729 women and trained 300+ community-based clinicians in seven countries. We helped pioneer the Single Visit Approach, which has become the gold standard in hard-to-reach places. The effectiveness of this approach is based on a simple premise: fewer women will be lost to follow-up care if they can receive treatment during the same visit in which they are screened.
It is now time to show that it is possible to use the newest screening and treatment technologies within a single visit. We cannot lose this critical part of the success of a program as new technologies are introduced. We at Grounds for Health have the ability to stay nimble as we innovate and share.